Novo Nordisk Drops, Puma Down, Trainline Rises

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:

- Novo Nordisk shares fall as much as 2% on Tradegate after the obesity drug giant was downgraded at Morgan Stanley. Analysts believe its valuation does not reflect “subdued” mid-term growth prospects.

- Puma’s Chief Commercial Officer Matthias Baeumer will step down from the management board on Sept. 30, according to a statement.

- Trainline shares climb as much as 8.8%, the most since November, after the train ticket retailer reported strong results in its first-half trading update. The group reiterated its revenue forecast for the full year and announced a new buyback worth £100 million.

See omnystudio.com/listener for privacy information.